We are pleased to invite you to attend the upcoming NAMS, AI & 3Rs Symposium, a collaborative event focused on the future of innovative preclinical research, emerging technologies, and ethical scientific advancement.
The symposium will bring together industry experts, researchers, regulatory specialists, and technology leaders to explore how advances in Artificial Intelligence and New Approach Methodologies (NAMs) are shaping the future of drug development and translational science while supporting the principles of the 3Rs – Replacement, Reduction, and Refinement.
Event Highlights will include
- Expert presentations on AI-driven approaches in preclinical and translational research
- Case studies demonstrating practical applications of NAMs
- Discussions on regulatory expectations and future industry direction
- Opportunities to network with peers across biotech, pharma, CROs, and academia
- Interactive sessions focused on integrating innovative technologies into development strategies
This symposium aims to encourage open discussion, collaboration, and knowledge sharing across the scientific community as we collectively work toward more efficient, predictive, and ethical research models.
Participation in this symposium is free of charge, but registration is required.
Date: Tuesday, 8 September 2026
Time: 8:00 – 16:00
Venue: Novo Nordisk Park 1, Måløv, Denmark